Por: CBS News Politics July 27, 2023
A pill being developed to treat is showing promise for new parents who suffer from the condition, according to newly released clinical trial data., published Wednesday in The American Journal of Psychiatry, found the drug, zuranolone, from makers Sage Therapeutics and partner company Biogen, demonstrated significant improvements in depressive symptoms and was generally well tolerated.The late stage, double-blind trial analyzed nearly 200... + full article
ABC7 USA Health August 05, 2023
for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for postpartum depression, a serious mental illness that can develop in new mothers after childbirth.On Friday, the FDA announced that the treatment, to be... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
CBS News USA Politics August 05, 2023
The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae by drugmakers Sage Therapeutics and Biogen. Zuranolone is approved for use in... + más
1st pill to treat postpartum depression moves to FDA for review | ABC News
FDA sets a decision date for Sage’s postpartum depression pill | The Boston Globe
ABC News USA Life July 27, 2023
A pill for led to meaningful improvements in depression symptoms, according to a late-stage published Wednesday in The American Journal of Psychiatry.The pill, zuranolone, is not yet approved, but the Food and Drug Administration is expected to make its approval decision by Aug... + más
Mom goes viral sharing reality of her postpartum body | ABC News
Kylie Jenner reveals she had postpartum depression twice | ABC News
ABC7 USA World July 27, 2023
led to meaningful improvements in depression symptoms, according to a late-stage published Wednesday in The American Journal of Psychiatry.The pill, zuranolone, is not yet approved, but the Food and Drug Administration is expected to make its approval decision by Aug 5.In the... + más
New York Post USA Life February 08, 2023
A first-of-its-kind pill for postpartum depression could be available to women in the US by August. The medication, called Zuranolone, is an antidepressant that is only taken for two weeks and is in a class of drugs that target GABA receptors — which control signaling in the... + más
I wanted to put a knife into my baby: Moms on their postpartum psychosis | Newsweek
ABC News USA Life February 08, 2023
A first-of-its-kind pill designed to help treat is one step closer to being available to new mothers.The drug, called Zuranolone, is now being reviewed by the U.S. Food and Drug Administration, which has until Aug. 5, 2023, to decide whether or not to approve the drug based on... + más
First pill for postpartum depression could be approved by August: FDA | New York Post
The Boston Globe USA Business February 06, 2023
An experimental drug that in a clinical trial helped some women quickly recover from postpartum depression could be approved by federal regulators by Aug. 6. The medicine, developed by Sage Therapeutics, is poised to become the first pill for the condition, which afflicts as... + más
A pill for postpartum depression is on the horizon | The Boston Globe
About iurex | Privacy Policy | Disclaimer |